Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Kidney International|August 25, 2024
Targeting APRIL in the treatment of glomerular diseasesChee Kay Cheung, Jonathan Barratt, Richard Lafayette, et al.
Kidney International Reports|December 22, 2025
Evaluating Sibeprenlimab in IgA Nephropathy - Rationale and Baseline Data from the VISIONARY TrialVlado Perkovic, Jonathan Barratt, Richard Lafayette, et al.
BMC Nephrology|June 1, 2022
SARS-COV-2 vaccine responses in renal patient populationsRona M Smith, Daniel J Cooper, Rainer Doffinger, et al.
The New England Journal of Medicine|November 10, 2025
Sibeprenlimab in IgA Nephropathy - Interim Analysis of a Phase 3 TrialVlado Perkovic, Hernán Trimarchi, Vladimir Tesar, et al.
Autoimmunity Reviews|September 17, 2020
Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?Philipp Gauckler, Jae Il Shin, Federico Alberici, et al.
Clinical Kidney Journal|April 10, 2025
Integrated primary and secondary care optimizes the management of people with CKD-the LUCID projectRupert W Major, Niraj Lakhani, Yaseen Ahmed, et al.
Pageof 4